The Probiotic VSL#3^® Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

• Main Authors: Elena P. Calandre (Author), Javier Hidalgo-Tallon (Author), Rocio Molina-Barea (Author), Fernando Rico-Villademoros (Author), Cristina Molina-Hidalgo (Author), Juan M. Garcia-Leiva (Author), Maria Dolores Carrillo-Izquierdo (Author), Mahmoud Slim (Author)
• Format: Book
• Published: MDPI AG, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Gastrointestinal symptomatology is frequent among patients with fibromyalgia, which increases disease burden and lacks specific treatment, either pharmacological or non-pharmacological. We aimed to evaluate the efficacy and tolerability of a multi-strain probiotic, VSL#3^®, for...